Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

688091 Shanghai Yizhong Pharmaceutical

95.200
+2.320+2.50%
Trading Session 09/30 10:19 CCT
High
96.380
Open
93.070
Turnover
49.74M
Low
92.570
Pre Close
92.880
Volume
5.23K
Market Cap
10.07B
P/E(TTM)
145.57
52wk High
198.880
Shares
105.80M
P/E(Static)
Loss
52wk Low
40.500
Float Cap
7.29B
Bid/Ask %
-35.16%
Historical High
198.880
Shs Float
76.61M
Volume Ratio
2.20
Historical Low
38.420
Dividend TTM
--
Div Yield TTM
--
P/B
8.15
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.68%
Amplitude
4.10%
Avg Price
95.085
Lot Size
100
Float Cap
7.29B
Bid/Ask %
-35.16%
Historical High
198.880
Shs Float
76.61M
Volume Ratio
2.20
Historical Low
38.420
Dividend TTM
--
Limit Up
111.460
P/B
8.15
Dividend LFY
--
Limit Down
74.300
Turnover Ratio
0.68%
Amplitude
4.10%
Avg Price
95.085
Lot Size
100
Ask
2.31Klots
Bid
2.68Klots
Price Forecast

No Data

News

Comment

No More
Company Overview More
The company is committed to the development of new dosage forms of antineoplastic drugs and related products. The company is committed to the R & D and industrialization of improved new drugs for antineoplastic drugs, with high-tech talents with the background of polymer materials, pharmaceutical preparations and biology, and mastering the core and key technologies for the synthesis of nano-drug carriers and medicinal polymer excipients. The company's main research and development product is paclitaxel micelles. Paclitaxel micelle is an innovative lyophilized powder injection without polyoxyethylene castor oil and methoxy polyethylene glycol 2000-poly (lactide) copolymer as carrier.
CEO: Jingsong Zhou
Market: --
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...